FDA Approves Vectibix to Treat Patients with Metastatic Colorectal Cancer
Vectibix treats colorectal cancer that's spread
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved Vectibix
Share this content.
If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.